Status:
COMPLETED
Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
Lead Sponsor:
Mann Eye Institute
Collaborating Sponsors:
Sengi
Conditions:
Cataract
Eligibility:
All Genders
50+ years
Brief Summary
This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinica...
Eligibility Criteria
Inclusion
- • Patients aged 50 years and older who underwent bilateral cataract surgery with Odyssey IOL implantation.
Exclusion
- Significant ocular comorbidities (e.g., macular degeneration, glaucoma).
- \< 2 weeks post YAG capsulotomy.
- Best corrected distance visual acuity worse than 20/25.
Key Trial Info
Start Date :
September 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 26 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06550375
Start Date
September 5 2024
End Date
March 26 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mann Eye Institute
Houston, Texas, United States, 76134-2099